Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
- PMID: 19945914
- DOI: 10.1016/S1474-4422(09)70272-8
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
Erratum in
- Lancet Neurol. 2010 Mar;9(3):237
Abstract
Optimum management of Duchenne muscular dystrophy (DMD) requires a multidisciplinary approach that focuses on anticipatory and preventive measures as well as active interventions to address the primary and secondary aspects of the disorder. Implementing comprehensive management strategies can favourably alter the natural history of the disease and improve function, quality of life, and longevity. Standardised care can also facilitate planning for multicentre trials and help with the identification of areas in which care can be improved. Here, we present a comprehensive set of DMD care recommendations for management of rehabilitation, orthopaedic, respiratory, cardiovascular, gastroenterology/nutrition, and pain issues, as well as general surgical and emergency-room precautions. Together with part 1 of this Review, which focuses on diagnosis, pharmacological treatment, and psychosocial care, these recommendations allow diagnosis and management to occur in a coordinated multidisciplinary fashion.
Copyright (c) 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Nutritional and Gastrointestinal Management of the Patient With Duchenne Muscular Dystrophy.Pediatrics. 2018 Oct;142(Suppl 2):S53-S61. doi: 10.1542/peds.2018-0333G. Pediatrics. 2018. PMID: 30275249
-
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.Lancet Neurol. 2010 Jan;9(1):77-93. doi: 10.1016/S1474-4422(09)70271-6. Epub 2009 Nov 27. Lancet Neurol. 2010. PMID: 19945913 Review.
-
Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.Lancet Neurol. 2018 Apr;17(4):347-361. doi: 10.1016/S1474-4422(18)30025-5. Epub 2018 Feb 3. Lancet Neurol. 2018. PMID: 29395990 Free PMC article. Review.
-
Update on the management of Duchenne muscular dystrophy.Arch Dis Child. 2008 Nov;93(11):986-90. doi: 10.1136/adc.2007.118141. Epub 2008 Jul 30. Arch Dis Child. 2008. PMID: 18667451 Review.
-
Standards of care for Duchenne muscular dystrophy: brief TREAT-NMD recommendations.Adv Exp Med Biol. 2009;652:13-21. doi: 10.1007/978-90-481-2813-6_2. Adv Exp Med Biol. 2009. PMID: 20225016
Cited by
-
Perks of Rehabilitation in Improving Motor Function in a Nine-Year-Old Male With Duchenne Muscular Dystrophy: A Case Report.Cureus. 2022 Oct 11;14(10):e30162. doi: 10.7759/cureus.30162. eCollection 2022 Oct. Cureus. 2022. PMID: 36397889 Free PMC article.
-
Longitudinal Evaluation of Muscle Composition Using Magnetic Resonance in 4 Boys With Duchenne Muscular Dystrophy: Case Series.Phys Ther. 2015 Jul;95(7):978-88. doi: 10.2522/ptj.20140234. Epub 2015 Jan 15. Phys Ther. 2015. PMID: 25592189 Free PMC article.
-
Facing Muscular Dystrophy During Covid-19 Pandemic: The Role of Support Associations and Spirituality.Pastoral Psychol. 2022;71(2):217-231. doi: 10.1007/s11089-022-00997-2. Epub 2022 Feb 3. Pastoral Psychol. 2022. PMID: 35132281 Free PMC article.
-
Hyperbaric therapy provides no benefit for skeletal muscle and respiratory function and accelerates cardiac injury in mdx mice.Sci Rep. 2019 Aug 23;9(1):12306. doi: 10.1038/s41598-019-48744-7. Sci Rep. 2019. PMID: 31444390 Free PMC article.
-
Importance of long-term motor function evaluation after prednisolone treatment for Duchenne muscular dystrophy.J Phys Ther Sci. 2018 Sep;30(9):1211-1214. doi: 10.1589/jpts.30.1211. Epub 2018 Sep 4. J Phys Ther Sci. 2018. PMID: 30214127 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical